No Data
Sanbo Neurology: Report for the first quarter of 2025
Sanbo Brain Science (301293.SZ) announced its first-quarter performance, with a net income of 38.3136 million yuan, an increase of 14.56%.
Sanbo Neuroscience (301293.SZ) released the first quarter report for 2025, with the company's revenue at 3.93...
Sanbo Hospital Management Group's (SZSE:301293) Solid Profits Have Weak Fundamentals
Sanbo Neuroscience (301293.SZ): No plans to develop in Hainan Development Holdings Nanhai at this time.
Gelonghui April 23丨Sanbo Neuroscience (301293.SZ) stated on the interactive platform that the company currently operates 8 Hospitals, located in Peking, Chongqing, Kunming, Fujian, Chengdu, and Zhengzhou and Luoyang in Henan, with two more Hospitals under construction in Xi'an and Hunan; there are currently no plans for Hainan Development Holdings Nanhai.
The chairman of Sanbo Neuroscience has been taken into custody for investigation. Just five days ago, he was still presiding over the Board of Directors meeting | Quick read announcement.
① Today, Sanbo Neuroscience announced that one of its actual controllers and the Chairman, Zhang Yang, has been detained and is under investigation; ② The specific reasons and time for lifting the detention have not been detailed in the announcement. Five days ago, Zhang Yang was still present at the company meeting room, where he convened and chaired the Board of Directors.
Sanbo Neurology: 2024 Annual Report Summary
Revenues Not Telling The Story For Sanbo Hospital Management Group Limited (SZSE:301293) After Shares Rise 27%
